Perspective Therapeutics (CATX) Gross Profit (2016 - 2023)
Perspective Therapeutics' Gross Profit history spans 14 years, with the latest figure at -$39000.0 for Q4 2023.
- On a quarterly basis, Gross Profit changed N/A to -$39000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $1.4 million, a 48.44% decrease, with the full-year FY2023 number at $1.4 million, changed N/A from a year prior.
- Gross Profit hit -$39000.0 in Q4 2023 for Perspective Therapeutics, down from $738000.0 in the prior quarter.
- Over the last five years, Gross Profit for CATX hit a ceiling of $1.7 million in Q1 2020 and a floor of -$39000.0 in Q4 2023.
- Historically, Gross Profit has averaged $971947.4 across 5 years, with a median of $1.1 million in 2020.
- Biggest five-year swings in Gross Profit: soared 135.88% in 2019 and later crashed 73.22% in 2023.
- Tracing CATX's Gross Profit over 5 years: stood at $1.1 million in 2019, then grew by 5.04% to $1.2 million in 2020, then increased by 4.54% to $1.2 million in 2021, then tumbled by 66.07% to $414000.0 in 2022, then crashed by 109.42% to -$39000.0 in 2023.
- Business Quant data shows Gross Profit for CATX at -$39000.0 in Q4 2023, $738000.0 in Q3 2023, and $248000.0 in Q2 2023.